On the public citation graph
Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS)
0 signed · 73 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2014.9646openalex-snapshot
Reanalyses of Randomized Clinical Trial Data
inferredcites →https://doi.org/10.1001/jama.2014.9647openalex-snapshot
Open Access to Clinical Trials Data
inferredcites →https://doi.org/10.1001/jama.300.10.1216openalex-snapshot
Principles and Practice of Clinical Research
inferredcites →https://doi.org/10.1016/b978-0-12-849905-4.00009-5openalex-snapshot
The Role and Importance of Clinical Trial Registries and Results Databases
inferredcites →https://doi.org/10.1056/nejme1307268openalex-snapshot
Participant-Level Data and the New Frontier in Trial Transparency
inferredcites →https://doi.org/10.1056/nejmhle1309073openalex-snapshot
Preparing for Responsible Sharing of Clinical Trial Data
inferredcites →https://doi.org/10.1056/nejmp1415160openalex-snapshot
Sharing Individual Patient Data from Clinical Trials
inferredcites →https://doi.org/10.1061/(asce)co.1943-7862.0001263openalex-snapshot
Data Availability Policy
inferredcites →https://doi.org/10.1097/00004583-200107000-00010openalex-snapshot
Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial
inferredcites →https://doi.org/10.1126/science.1153632openalex-snapshot
Moving Toward Transparency of Clinical Trials
inferredcites →https://doi.org/10.1136/bmj.f2865openalex-snapshot
Restoring invisible and abandoned trials: a call for people to publish the findings
inferredcites →https://doi.org/10.1136/bmj.h4320openalex-snapshot
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence
inferredcites →https://doi.org/10.1186/1741-7015-8-18openalex-snapshot
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
inferredcites →https://doi.org/10.1371/journal.pmed.1000251openalex-snapshot
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials
inferredcites →https://doi.org/10.1371/journal.pmed.1001202openalex-snapshot
Open Clinical Trial Data for All? A View from Regulators
inferredcites →https://doi.org/10.1371/journal.pmed.1001855openalex-snapshot
Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use
inferredcites →https://doi.org/10.1371/journal.pone.0097886openalex-snapshot
Sharing Individual Participant Data from Clinical Trials: An Opinion Survey Regarding the Establishment of a Central Repository
inferredcites →https://doi.org/10.1542/peds.2005-0074openalex-snapshot
The Food and Drug Administration’s Deliberations on Antidepressant Use in Pediatric Patients
inferredcites →https://doi.org/10.3233/jrs-2008-0426openalex-snapshot
Clinical trials and drug promotion: Selective reporting of study 329
inferredcites →https://doi.org/10.3233/jrs-2008-0444openalex-snapshot
Clinical trials and drug promotion: Selective reporting of Study 329
inferredcites →https://doi.org/10.3310/hta14080openalex-snapshot
Dissemination and publication of research findings: an updated review of related biases
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4716353openalex-extracted
Researcher Access to Social Media Data: Lessons from Clinical Trial Data Sharing
inferred← citeshttps://doi.org/10.1001/jama.2017.20581openalex-snapshot
Trialists’ Intent to Share Individual Participant Data as Disclosed at ClinicalTrials.gov
inferred← citeshttps://doi.org/10.1002/jrsm.1500openalex-snapshot
Data sharing—trialists' plans at registration, attitudes, barriers and facilitators: A cohort study and cross‐sectional survey
inferred← citeshttps://doi.org/10.1002/jrsm.1545openalex-snapshot
Identifying unreported links between ClinicalTrials.gov trial registrations and their published results
inferred← citeshttps://doi.org/10.1002/jrsm.1672openalex-snapshot
A comparison of machine learning methods to find clinical trials for inclusion in new systematic reviews from their PROSPERO registrations prior to searching and screening
inferred← citeshttps://doi.org/10.1007/978-3-030-86778-2_2openalex-snapshot
The Context and the Problem
inferred← citeshttps://doi.org/10.1007/978-3-030-86778-2_3openalex-snapshot
Secondary Analysis of Individual Patient-Level Clinical Trial Data: A Primer
inferred← citeshttps://doi.org/10.1007/978-3-319-98779-8_21openalex-snapshot
Clinical Trial Registries, Results Databases, and Research Data Repositories
inferred← citeshttps://doi.org/10.1007/s11121-023-01586-2openalex-snapshot
Addressing Systematic Missing Data in the Context of Causally Interpretable Meta-analysis
inferred← citeshttps://doi.org/10.1016/b978-0-12-849905-4.00009-5openalex-snapshot
The Role and Importance of Clinical Trial Registries and Results Databases
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2017.12.007openalex-snapshot
Unreported links between trial registrations and published articles were identified using document similarity measures in a cross-sectional analysis of ClinicalTrials.gov
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2018.12.014openalex-snapshot
Software engineering principles address current problems in the systematic review ecosystem
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2019.02.015openalex-snapshot
The risk of conclusion change in systematic review updates can be estimated by learning from a database of published examples
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2020.03.026openalex-snapshot
Individual participant data meta-analyses (IPDMA): data contribution was associated with trial corresponding author country, publication year, and journal impact factor
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2023.08.006openalex-snapshot
Depression screening tool accuracy individual participant data meta-analyses: data contribution was associated with multiple factors
inferred← citeshttps://doi.org/10.1016/j.zefq.2016.11.003openalex-snapshot
Beyond journal publications – a new format for the publication of clinical trials
inferred← citeshttps://doi.org/10.1017/dap.2023.26openalex-snapshot
Individual participant data sharing intentions and practices during the coronavirus disease-2019 pandemic: A rapid review
inferred← citeshttps://doi.org/10.1051/ject/202052126openalex-snapshot
When Evidence Goes “Missing in Action”: Implications for Patient Management in Cardiac Surgery
inferred← citeshttps://doi.org/10.1056/nejmsa1603542openalex-snapshot
Use of the National Heart, Lung, and Blood Institute Data Repository
inferred← citeshttps://doi.org/10.1056/nejmsr1601330openalex-snapshot
Update on Trial Registration 11 Years after the ICMJE Policy Was Established
inferred← citeshttps://doi.org/10.1056/nejmsr1907644openalex-snapshot
10-Year Update on Study Results Submitted to ClinicalTrials.gov
inferred← citeshttps://doi.org/10.1073/pnas.1919906117openalex-snapshot
P-hacking in clinical trials and how incentives shape the distribution of results across phases
inferred← citeshttps://doi.org/10.1080/21614083.2021.1989172openalex-snapshot
Centralised Full Access to Clinical Study Data Can Support Unbiased Guideline Development, Continuing Medical Education, and Patient Information
inferred← citeshttps://doi.org/10.1093/intqhc/mzx076openalex-snapshot
Linking quality indicators to clinical trials: an automated approach
inferred← citeshttps://doi.org/10.1093/jamia/ocaa035openalex-snapshot
Is it time for computable evidence synthesis?
inferred← citeshttps://doi.org/10.1093/jamia/ocx050openalex-snapshot
Evidence appraisal: a scoping review, conceptual framework, and research agenda
inferred← citeshttps://doi.org/10.1111/jebm.12268openalex-snapshot
Innovation of clinical trials in China: Commentary on the publication of “CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration”
inferred← citeshttps://doi.org/10.1136/bmj.i5543openalex-snapshot
Is this trial misreported? Truth seeking in the burgeoning age of trial transparency
inferred← citeshttps://doi.org/10.1136/bmj.j2782openalex-snapshot
Focus on sharing individual patient data distracts from other ways of improving trial transparency
inferred← citeshttps://doi.org/10.1136/bmj.k1452openalex-snapshot
How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider
inferred← citeshttps://doi.org/10.1136/bmj.k400openalex-snapshot
Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published inThe BMJandPLOS Medicine
inferred← citeshttps://doi.org/10.1136/bmjebm-2020-111566openalex-snapshot
From publication bias to lost in information: why we need a central public portal for clinical trial data
inferred← citeshttps://doi.org/10.1136/bmjopen-2019-029475openalex-snapshot
Mapping the preclinical to clinical evidence and development trajectory of the oncolytic virus talimogene laherparepvec (T-VEC): a systematic review
inferred← citeshttps://doi.org/10.1177/00236772261462343openalex-snapshot
Reporting and transparency in laboratory animal science: Past achievements, present concerns and future directions
inferred← citeshttps://doi.org/10.1177/1073110519876165openalex-snapshot
How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers
inferred← citeshttps://doi.org/10.1182/ject-2000020openalex-snapshot
When Evidence Goes "Missing in Action": Implications for Patient Management in Cardiac Surgery.
inferred← citeshttps://doi.org/10.1186/s12916-016-0612-8openalex-snapshot
Sharing all types of clinical data and harmonizing journal standards
inferred← citeshttps://doi.org/10.1186/s12916-022-02377-2openalex-snapshot
Data-sharing and re-analysis for main studies assessed by the European Medicines Agency—a cross-sectional study on European Public Assessment Reports
inferred← citeshttps://doi.org/10.1186/s13063-017-1836-4openalex-snapshot
Clinical trial registries: more international, converging efforts are needed
inferred← citeshttps://doi.org/10.1186/s13643-017-0518-3openalex-snapshot
A systematic review of the processes used to link clinical trial registrations to their published results
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1010879openalex-snapshot
Ten (not so) simple rules for clinical trial data-sharing
inferred← citeshttps://doi.org/10.1371/journal.pmed.1001949openalex-snapshot
Can Data Sharing Become the Path of Least Resistance?
inferred← citeshttps://doi.org/10.2196/preprints.37460openalex-snapshot
Individual Participant Data Sharing during the COVID-19 Pandemic: A Review of Individual Participant Data Sharing Intentions and Practices from Clinical Trials (Preprint)
inferred← citeshttps://doi.org/10.2196/preprints.90860openalex-snapshot
Implementation of Individual Patient Data (IPD) Sharing Strategies in the VACCELERATE Project: A Case Study of COVID-19 Vaccine Trials (Preprint)
inferred← citeshttps://doi.org/10.31478/201906bopenalex-snapshot
Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing
inferred← citeshttps://doi.org/10.6084/m9.figshare.19802426openalex-snapshot
Additional file 1 of Data-sharing and re-analysis for main studies assessed by the European Medicines Agency—a cross-sectional study on European Public Assessment Reports
inferred← citeshttps://doi.org/10.6084/m9.figshare.19802429openalex-snapshot
Additional file 2 of Data-sharing and re-analysis for main studies assessed by the European Medicines Agency—a cross-sectional study on European Public Assessment Reports
inferred← citeshttps://doi.org/10.6084/m9.figshare.19802432openalex-snapshot
Additional file 3 of Data-sharing and re-analysis for main studies assessed by the European Medicines Agency—a cross-sectional study on European Public Assessment Reports
inferred← citeshttps://doi.org/10.6084/m9.figshare.19802435openalex-snapshot
Additional file 4 of Data-sharing and re-analysis for main studies assessed by the European Medicines Agency—a cross-sectional study on European Public Assessment Reports
inferred← citeshttps://doi.org/10.6084/m9.figshare.19802438openalex-snapshot
Additional file 5 of Data-sharing and re-analysis for main studies assessed by the European Medicines Agency—a cross-sectional study on European Public Assessment Reports
inferred← citeshttps://doi.org/10.6084/m9.figshare.19802441openalex-snapshot
Additional file 6 of Data-sharing and re-analysis for main studies assessed by the European Medicines Agency—a cross-sectional study on European Public Assessment Reports
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.